BusinessAXIM Biotech Holds Bi-Annual Board Meeting in New York City on July 8By Nasdaq OMXJul 12, 2017, 1:00 PM UTC
BusinessCURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel’s Assuta Medical Centers to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & CannabinoidsBy Nasdaq OMXJul 11, 2017, 1:00 PM UTC
BusinessCURE Pharmaceutical Expects Increased Demand for Its Enhanced Transdermal Drug Delivery PlatformBy Nasdaq OMXJul 5, 2017, 1:00 PM UTC
BusinessEarth Science Tech, Inc. Receives a Price Target of $4.12 from Leading Independent Equity Research & Corporate Firm, SeeThruEquityBy Nasdaq OMXJun 29, 2017, 12:45 PM UTC
BusinessComprehensive Study by AstraZeneca and Genentech Confirms Superiority of InSphero Human Liver Microtissues for Prediction of Drug-Induced Liver InjuryBy Nasdaq OMXJun 29, 2017, 12:00 PM UTC
BusinessSmokeless Medical Cannabis Products Released in New MexicoBy Nasdaq OMXJun 27, 2017, 9:11 PM UTC
BusinessCURE Pharmaceutical Appoints CannaKids CEO and Cannabis Cancer Advocate Tracy Ryan to Advisory BoardBy Nasdaq OMXJun 27, 2017, 1:00 PM UTC
